FDA Insider Trading Scheme Concludes With Guilty Plea
This article was originally published in The Pink Sheet Daily
Executive Summary
The first-ever prosecution of an agency employee will likely result in jail time for the chemist. For the agency, the result is a new electronic monitoring system.
You may also be interested in...
FDA's Confidential Information Protections Draw Questions From Congress
House Energy & Commerce Committee leaders ask what additional steps agency has taken to safeguard trade secrets in wake of insider trading charges against former FDA official.
Insider Trading: Pharma Employees Increasingly In SEC Crosshairs
In past month, three individuals in biopharma space have been charged with insider trading despite efforts by companies and associations to protect confidential information; past sentencing suggests length of jail time former FDA official Gordon Johnston is likely to face.
FDA Seeks New Chief Information Officer In Privacy And Security Overhaul
The CIO will help develop policy to protect sensitive information while balancing individual privacy and security. FDA restructured the organization with a chief health informatics officer – focused on research, development, scientific computing and big data – and the CIO for software development and deployment, infrastructure and customer service.